Future Plans and Projects

INTERMED realizes and recognizes the interdependence on the buyer, provider (supply chain) and other pharmaceutical value chains.

INTERMED will continue to invest in developing medicines that the market wants to buy and will always adopt a more flexible policy on pricing and will focus their its efforts on multi Country launches of their products in the future with innovative molecules with good presentation and get up on packaging as per prescribed norms in the Pharmacopeias.

To bring down the delivery period and costs and to get better access to the wholesalers and to the direct consumers, INTERMED is also planning a vertical integration by to opening Depots manned by adequate marketing and sales force globally in tangible markets.

Will focus our efforts on R & D and better productivity and to meet the future technological challenges, we have earmarked funds will soon set up a state-of-the-art factory as per US-FDA standards to gear up for UK-MHRA,MCC, South Africa, GCC, ANVISA, Brazil , TGA, Australia and US-FDA in a phased manner. This will enable the Company to do CONTRACT MANUFACTURING for the Pharma Industry from developed Countries.

Finance And System

INTERMED has been generating profits since THE LAST ONE DECADE and a major portion of its profits are being ploughed back every year to continuously to upgrade manufacturing capabilities and innovative formulations development.

Our bankers proudly confirm that the company has good financial discipline and its capital base is sound.

All the financial parameters are well within norms and the company is firm in meeting the commitments in time.

Systems

The company has sound infrastructure in IT. With the wireless lease line from Airtel, the speed is well directed. The plant and the corporate office is also connected through wireless lease line. The company is poised for implementing ERP across different functions within the organization.

Go To Top